These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11171894)
1. APOE genotype is a major predictor of long-term progression of disability in MS. Chapman J; Vinokurov S; Achiron A; Karussis DM; Mitosek-Szewczyk K; Birnbaum M; Michaelson DM; Korczyn AD Neurology; 2001 Feb; 56(3):312-6. PubMed ID: 11171894 [TBL] [Abstract][Full Text] [Related]
2. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis. Chapman J; Sylantiev C; Nisipeanu P; Korczyn AD Arch Neurol; 1999 Dec; 56(12):1484-7. PubMed ID: 10593303 [TBL] [Abstract][Full Text] [Related]
3. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis. Pinholt M; Frederiksen JL; Andersen PS; Christiansen M Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886 [TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis. Tamam Y; Tasdemir N; Yalman M; Tamam B Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672 [TBL] [Abstract][Full Text] [Related]
5. Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele. Enzinger C; Ropele S; Strasser-Fuchs S; Kapeller P; Schmidt H; Poltrum B; Schmidt R; Hartung HP; Fazekas F Arch Neurol; 2003 Jan; 60(1):65-70. PubMed ID: 12533090 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype does not influence the progression of multiple sclerosis. Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972 [TBL] [Abstract][Full Text] [Related]
7. No association of apolipoprotein E epsilon4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis. Sedano MI; Calmarza P; Perez L; Trejo JM Mult Scler; 2006 Feb; 12(1):13-8. PubMed ID: 16459715 [TBL] [Abstract][Full Text] [Related]
8. Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate. Høgh P; Oturai A; Schreiber K; Blinkenberg M; Jørgensen OS; Ryder L; Paulson OB; Sørensen PS; Knudsen GM Mult Scler; 2000 Aug; 6(4):226-30. PubMed ID: 10962542 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Fazekas F; Strasser-Fuchs S; Kollegger H; Berger T; Kristoferitsch W; Schmidt H; Enzinger C; Schiefermeier M; Schwarz C; Kornek B; Reindl M; Huber K; Grass R; Wimmer G; Vass K; Pfeiffer KH; Hartung HP; Schmidt R Neurology; 2001 Sep; 57(5):853-7. PubMed ID: 11552016 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score. Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422 [TBL] [Abstract][Full Text] [Related]
11. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402 [TBL] [Abstract][Full Text] [Related]
12. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis. Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690 [TBL] [Abstract][Full Text] [Related]
13. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis. Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984 [TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms. Parmenter BA; Denney DR; Lynch SG; Middleton LS; Harlan LM Mult Scler; 2007 Jan; 13(1):25-32. PubMed ID: 17294608 [TBL] [Abstract][Full Text] [Related]
15. Association of the APOE epsilon4 allele with disease activity in multiple sclerosis. Evangelou N; Jackson M; Beeson D; Palace J J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):203-5. PubMed ID: 10406990 [TBL] [Abstract][Full Text] [Related]
16. APOE genotypes and disease severity in multiple sclerosis. Masterman T; Zhang Z; Hellgren D; Salter H; Anvret M; Lilius L; Lannfelt L; Hillert J Mult Scler; 2002 Apr; 8(2):98-103. PubMed ID: 11990879 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis. Weatherby SJ; Mann CL; Davies MB; Carthy D; Fryer AA; Boggild MD; Young C; Strange RC; Ollier W; Hawkins CP Mult Scler; 2000 Feb; 6(1):32-6. PubMed ID: 10694843 [TBL] [Abstract][Full Text] [Related]
18. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients]. Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis. Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480 [TBL] [Abstract][Full Text] [Related]